#BXT-110
LightNews LightNews
madisonstartups.com
BrainXell Sees Progress Toward Parkinson's Disease: www.madisonstartups.com/brainxell-se...

#biotech
BrainXell Sees Progress Toward Parkinson's Disease - Startup and Tech News - Madison Startups
BrainXell Therapeutics announced recently preclinical data demonstrating the efficacy of its neuronal therapy called BXT-110 as a potential disease-modifying
www.madisonstartups.com
December 30, 2025 at 7:43 PM
newsen.bsky.social
BrainXell Unveils Groundbreaking Research on iPSC Therapy at 2025 SfN Meeting#United_States#San_Diego#iPSC_therapy#BrainXell#BXT-110
BrainXell Unveils Groundbreaking Research on iPSC Therapy at 2025 SfN Meeting
BrainXell is set to showcase innovative findings on iPSC-derived therapies for Parkinson's Disease, focusing on BXT-110 during the 2025 SfN meeting in San Diego.
third-news.com
November 15, 2025 at 4:12 PM
newsen.bsky.social
BrainXell Therapeutics Announces Promising Preclinical Study Results for iPSC-Derived Neuronal Therapy in Parkinson’s Disease#USA#San_Diego#Parkinson's#BrainXell#BXT-110
BrainXell Therapeutics Announces Promising Preclinical Study Results for iPSC-Derived Neuronal Therapy in Parkinson’s Disease
BrainXell Therapeutics has revealed groundbreaking preclinical results for BXT-110, an iPSC-derived therapy targeting Parkinson's disease, showing significant promise for future treatments.
third-news.com
November 3, 2025 at 5:02 PM
l2plabs.bsky.social
BrainXell Showcases Pioneering iPSC Research and Promising In Vivo Data for BXT-110 for Parkinson's Disease at the 2025 Society for Neuroscience Annual Meeting
SAN DIEGO, Nov. 15, 2025 /PRNewswire/ -- BrainXell, Inc. today announced that data will be presented during poster sessions at the 2025 Society for Neuroscience (SfN) Annual Meeting in San Diego, highlighting new breakthroughs in human iPSC-derived cell models and regenerative...
dlvr.it
November 15, 2025 at 4:34 PM